Cartesian Therapeutics
RNAC
#6787
Rank
NZ$0.81 B
Marketcap
$31.89
Share price
11.91%
Change (1 day)
-44.52%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -$0.53

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.55. In 2021 the company made an earnings per share (EPS) of -$0.41 an increase over its 2020 EPS that were of -$1.18.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.53
2021-$0.41-65.22%
2020-$1.18-43.44%
2019-$2.09-58.08%
2018-$4.99-9.35%
2017-$5.50-29.16%
2016-$7.77